Cargos activos de Sri Mudumba
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | - | - |
| Director Técnico/Científico/I+D | - | - |
Historial de carrera de Sri Mudumba
Antiguos cargos conocidos de Sri Mudumba.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MacuSight, Inc.
 MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Corporate Officer/Principal | 06/07/2010 | - |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Australia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
MacuSight, Inc.
MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Sri Mudumba
- Experiencia
